To determine whether EBV infected B cells from patients with MS can be killed by EBV specific CD8+ T cells, we used chromium release assays to measure the killing of LCL by HLA matched EBV specific CD8+ T cell clones derived from healthy subjects (table 3). The gene discussed is CD8A; the disease is myeloid sarcoma.